Roche Defeats Class Cert. Bid In Canadian Accutane Action
A Canadian court has refused to certify a class action against Hoffmann-La Roche Ltd. claiming the acne drug Accutane causes inflammatory bowel disease, saying the plaintiff had not demonstrated a causal...To view the full article, register now.
Already a subscriber? Click here to view full article